Abstract:High-definition endoscopy is one essential step in the initial diagnosis of inflammatory bowel disease (IBD) characterizing the extent and severity of inflammation, as well as discriminating ulcerative colitis (UC) from Crohn's disease (CD). Following general recommendations and national guidelines, individual risk stratification should define the appropriate surveillance strategy, biopsy protocol and frequency of endoscopies. Beside high-definition videoendoscopy the application of dyes applied via a spraying catheter is of additional diagnostic value with a higher detection rate of intraepithelial neoplasia (IEN). Virtual chromoendoscopy techniques (NBI, FICE, I-scan, BLI) should not be recommended as a single surveillance strategy in IBD, although newer data suggest a higher comparability to dye-based chromoendoscopy than previously assumed. First results of oral methylene blue formulation are promising for improving the acceptance rate of classical chromoendoscopy. Confocal laser endomicroscopy (CLE) is still an experimental but highly innovative endoscopic procedure with the potential to contribute to the detection of dysplastic lesions. Molecular endoscopy in IBD has taken application of CLE to a higher level and allows topical application of labeled probes, mainly antibodies, against specific target structures expressed in the tissue to predict response or failure to biological therapies. First pre-clinical and in vivo data from label-free multiphoton microscopy (MPM) are now available to characterize mucosal and submucosal inflammation on endoscopy in more detail. These new techniques now have opened the door to individualized and highly specific molecular imaging in IBD in the future and pave the path to personalized medicine approaches. The quality of evidence was stated according to the Oxford Center of evidence-based medicine (March 2009). For this review a Medline search up to January 2021 was performed using the words “inflammatory bowel disease,” “ulcerative colitis,” “crohn's disease,” “chromoendoscopy,” “high-definition endoscopy,” “confocal laser endomicroscopy,” “confocal laser microscopy,” “molecular imaging,” “multiphoton microscopy.”

New Diagnostic Avenues in Inflammatory Bowel Diseases

MR imaging of the small bowel

Diagnostic imaging advances in murine models of colitis

Innovative Diagnostic Endoscopy in Inflammatory Bowel Diseases: From High-Definition to Molecular Endoscopy

Bildgebende Diagnostik des Darms - eine Neubewertung, Teil 1

Imaging of Mucosal Inflammation: Current Technological Developments, Clinical Implications, and Future Perspectives

Up-to-date overview of imaging techniques in the diagnosis and management of inflammatory bowel diseases

[New methods for exploration of the small intestine]

Magnetic resonance enterography and intestinal ultrasound for the assessment and monitoring of Crohn’s disease

[Novel imaging methods in endoscopic diagnosis of gastrointestinal tumors]

Ultrasound in Pediatric Inflammatory Bowel Disease—A Review of the State of the Art and Future Perspectives

Advanced Endoscopic Imaging Techniques for the Study of Colonic Mucosa in Patients with Inflammatory Bowel Disease

Ultrasound of the bowel with a focus on IBD: the new best practice

Role of Intestinal Ultrasound for IBD Care: A Practical Approach

Evolution and New Horizons of Endoscopy in Inflammatory Bowel Diseases

Evolving role of endoscopy in inflammatory bowel disease: Going beyond diagnosis

Imaging of Ulcerative Colitis: The Role of Diffusion-Weighted Magnetic Resonance Imaging

Technological advances in inflammatory bowel disease endoscopy and histology

ECCO-ESGAR Topical Review on Optimizing Reporting for Cross-Sectional Imaging in Inflammatory Bowel Disease

Influence of diffusion weighted imaging and contrast enhanced T1 sequences on the diagnostic accuracy of magnetic resonance enterography for Crohn's disease

[Imaging Techniques and Differential Diagnosis for Inflammatory Bowel Disease]